AMGEN INC

AMGN · Large cap · Calculated market cap · $227.9B · as of 2026-09-30

Company Stats

Market Cap: $227.9B; as of Sep 30, 2026
Shares Outstanding: 540.9M
Free Float: 99.8%

Income Statement

Revenue: $36.8B
Operating Income: $9.1B
Net Income: $7.7B
EBITDA: $14.2B
Non-cash Impairment: $1.2B
Revenue Growth, 3Y: 11.8%
FCF Margin, 3Y Avg: 26.4%
FCF Margin, Worst Year: 22.0%

Cash Flow

Free Cash Flow: $8.1B
FCF Yield: 3.6%
Owner FCF Yield: 3.3%

Balance Sheet

Cash & Equivalents: $9.1B

Returns & Capital

Dividends Paid: $5.1B
Dividend Yield: 2.2%
Dividend Payout, 3Y Avg: 84.1%
Buyback Yield, 3Y Avg: 0.0%
SBC, 3Y Avg: $485.0M

Cash Flow by Year

Year	Revenue	FCF	Margin
FY2025	$36.8B	$8.1B	22.0%
FY2024	$33.4B	$10.4B	31.1%
FY2023	$28.2B	$7.4B	26.1%
FY2022	$26.3B	$8.8B	33.4%
FY2021	$26.0B	$8.4B	32.3%

Annual filing data through FY ended December 31, 2025; shares and float as of November 7, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.

Company RSS

Earnings

Nov 3, 2026Amgen Third-Quarter GAAP Profit Margin Widens as Revenue Growth Cools Aug 4, 2026Amgen's Product-Sales Growth Reaccelerates After a Slow Start

Other Coverage

November 7, 2026 Weekly Earnings

Earnings Roundup for Week of Nov. 2, 2026 September 28, 2026 QBook

Stronger demand supports expansion as pricing diverges September 23, 2026 Drug Pipeline

Lilly and Novo set the backdrop for a changing obesity pipeline September 23, 2026 Drug Pipeline

Amgen tests monthly obesity treatment with MariTide in Phase 3

The Tip Desk